Corporate Profile

QSV Biologics provides dedicated biopharmaceutical contract manufacturing services for process development & scale-up, pre-clinical research, Phase I, II and III clinical trial and commercial materials to biopharmaceutical firms developing protein therapeutic products. 

QSV was established in 2002 although the GMP manufacturing facility has been in operation since 1996. In early 2005 QSV completed commissioning and validation of two additional cGMP manufacturing suites as part of a 7,000 square foot extension of the existing facility.

QSV was issued a Health Canada Commercial Establishment License in 2006.

Through the strength and close team-work of our highly qualified technical staff, the company has developed and produced products for GMP biopharmaceuticals for phase III human clinical trials.

Mission Statement

QSV Biologics' mission is to become a value-added partner to our clients in providing an integral component in converting today's novel protein discoveries into life saving therapies and diagnostics.